DouglasAArenbergMD

PubMed

• 3 citations
  ENDS, Cigarettes, and Respiratory Illness: Longitudinal Associations Among U.S. Youth.
  Richa Mukerjee, Jana L Hirschtick, Luis Zavala Arciniega, Yanmei Xie, Geoffrey D Barnes, Douglas A Arenberg, David T Levy, Rafael Meza, Nancy L Fleischer, Steven F Cook> ;American Journal of Preventive Medicine. 2024 May 1
• Longitudinal associations between exclusive, dual and polytobacco use and respiratory illness among youth.
  Zavala-Arciniega, L., Cook, S., Hirschtick, J., Xie, Y., Mukerjee, R., Barnes, G., Levy, D., Meza, R., Fleischer, N., Arenberg, D.> ;Research Square. 2024 Jan 22
• Author Response to Issues for Studies on E-cigarettes and Chronic Obstructive Pulmonary Disorder.
  Steven F Cook, Nancy L Fleischer, Douglas A Arenberg, Rafael Meza> ;American Journal of Preventive Medicine. 2023 Dec 1
• Barriers to Timely Lung Cancer Care in Early Stage Non-Small Cell Lung Cancer and Impact on Patient Outcomes.
  Mina Pirzadeh, Madeline Lagina, Cameron Wood, Thomas Valley, Nithya Ramnath, Douglas Arenberg, Jane C Deng> ;Clinical Lung Cancer. 2024 Mar 1
• 6 citations
  Causes of and Clinical Features Associated with Death in Tobacco Cigarette Users by Lung Function Impairment.
  Moll, M., Bhatt, S. P., Wassim W Labaki, Tian Gu, Susan Murray, Jeffrey L Curtis, J Michael Wells, Surya P Bhatt, Jessica Bon, Alejandro A Diaz, Craig P Hersh, Emily S...> ;American Journal of Respiratory and Critical Care Medicine. 2023 Aug 15
• Lung Cancer Risk and Delivering on the Promise of the Genomic Era.
  Douglas Arenberg> ;American Journal of Respiratory and Critical Care Medicine. 2023 Aug 1
• 4 citations
  Longitudinal Association Between Exclusive and Dual Use of Cigarettes and Electronic Nicotine Delivery Systems and Asthma Among U.S. Adolescents.
  Akash Patel, Steven Cook, Delvon T Mattingly, Geoffrey D Barnes, Douglas A Arenberg, David T Levy, Rafael Meza, Nancy L Fleischer, Jana L Hirschtick> ;The Journal of Adolescent Health. 2023 Sep 1
• 2 citations
  Time-varying association between cigarette and ENDS use on incident hypertension among US adults: a prospective longitudinal study.
  Steven Cook, Jana L Hirschtick, Geoffrey Barnes, Douglas Arenberg, Irina Bondarenko, Akash Patel, Evelyn Jiminez Mendoza, Jihyoun Jeon, David Levy, Rafael Meza, Nancy ...> ;BMJ Open. 2023 Apr 21
• 3 citations
  Longitudinal associations between exclusive, dual, and polytobacco use and asthma among US youth.
  Delvon T Mattingly, Steven Cook, Jana L Hirschtick, Akash Patel, Douglas A Arenberg, Geoffrey D Barnes, David T Levy, Rafael Meza, Nancy L Fleischer> ;Preventive Medicine. 2023 Jun 1
• 5 citations
  Cigarettes, ENDS Use, and Chronic Obstructive Pulmonary Disease Incidence: A Prospective Longitudinal Study.
  Steven F Cook, Jana L Hirschtick, Nancy L Fleischer, Douglas A Arenberg, Geoffrey D Barnes, David T Levy, Luz Maria Sanchez-Romero, Jihyoun Jeon, Rafael Meza> ;American Journal of Preventive Medicine. 2023 Aug 1
• 5 citations
  Longitudinal Associations Between Exclusive and Dual Use of Electronic Nicotine Delivery Systems and Cigarettes and Self-Reported Incident Diagnosed Cardiovascular Dis...
  Jana L Hirschtick, Steven Cook, Akash Patel, Geoffrey D Barnes, Douglas Arenberg, Irina Bondarenko, David T Levy, Jihyoun Jeon, Evelyn Jimenez Mendoza, Rafael Meza, Na...> ;Nicotine & Tobacco Research. 2023 Feb 9
• 3 citations
  Temporal Trends and Variation in Bronchoscopy Use for Acute Respiratory Failure in the United States.
  Max T Wayne, Thomas S Valley, Douglas A Arenberg, Jose De Cardenas, Hallie C Prescott> ;Chest. 2023 Jan 1
• 79 citations
  Management of Stage III Non-Small-Cell Lung Cancer: ASCO Guideline.
  Megan E Daly, Navneet Singh, Nofisat Ismaila, Mara B Antonoff, Douglas A Arenberg, Jeffrey Bradley, Elizabeth David, Frank Detterbeck, Martin Früh, Matthew A Gubens, A...> ;Journal of Clinical Oncology. 2022 Apr 20
• 34 citations
  NAVIGATE 24-Month Results: Electromagnetic Navigation Bronchoscopy for Pulmonary Lesions at 37 Centers in Europe and the United States.
  Erik E Folch, Mark R Bowling, Michael A Pritchett, Septimiu D Murgu, Michael A Nead, Javier Flandes, William S Krimsky, Amit K Mahajan, Gregory P LeMense, Boris A Muri...> ;Journal of Thoracic Oncology. 2022 Apr 1
• 2 citations
  Prevalence and consequences of non-adherence to an evidence-based approach for incidental pulmonary nodules.
  Max T Wayne, Hallie C Prescott, Douglas A Arenberg> ;Plos One. 2022 Jan 1
• 1 citations
  Variation in US Hospital Practices for Bronchoscopy in the ICU
  Max T Wayne, Sarah Seelye, Daniel Molling, Cainnear K Hogan, Thomas S. Valley, Douglas A. Arenberg, Jose De Cardenas, Hallie C. Prescott> ;Annals of the American Thoracic Society. 2021 Nov 30
• Integrated Biomarkers for Pulmonary Nodules: Proving What Is Possible.
  Douglas A. Arenberg> ;American Journal of Respiratory and Critical Care Medicine. 2021 Sep 28
• 13 citations
  The Impact of Biopsy Tool Choice and Rapid On-Site Evaluation on Diagnostic Accuracy for Malignant Lesions in the Prospective: Multicenter NAVIGATE Study.
  Thomas R. Gildea, Erik Folch, Sandeep J. Khandhar, Michael A. Pritchett, Gregory P. LeMense, Philip A. Linden, Douglas A. Arenberg, Otis B. Rickman, Amit K. Mahajan, J...> ;Journal of Bronchology & Interventional Pulmonology. 2021 Jul 1
• 26 citations
  Quantitative Emphysema on Low-Dose CT Imaging of the Chest and Risk of Lung Cancer and Airflow Obstruction: An Analysis of the National Lung Screening Trial
  Wassim W. Labaki, Meng Xia, Susan Murray, Abdullah Al-abcha, M. Ferrera, Catherine A. Meldrum, Lauren A. Keith, Craig J. Galbán, Douglas A. Arenberg, Jeffrey L. Curtis...> ;Chest. 2021 May 1
• 11 citations
  Prediction of COPD risk accounting for time-varying smoking exposures
  Joanne T. Chang, Rafael Meza, David T. Levy, Douglas A. Arenberg, Jihyoun Jeon> ;Plos One. 2021 Mar 10
• 8 citations
  Lung Cancer Screening Knowledge, Perceptions, and Decision Making Among African Americans in Detroit, Michigan
  Yan Kwan Lau, Harihar Bhattarai, Tanner J. Caverly, Pei-Yao Hung, Evelyn Jimenez-Mendoza, Minal R. Patel, Michele L. Cote, Douglas A. Arenberg, Rafael Meza> ;American Journal of Preventive Medicine. 2021 Jan 1
• 31 citations
  Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic: CHEST Expert Panel Report.
  Peter J. Mazzone, Michael K. Gould, Douglas A. Arenberg, Alexander Chen, Humberto Choi, Frank C. Detterbeck, Farhood Farjah, Kwun M. Fong, Jonathan M. Iaccarino, Sam M...> ;Journal of the American College of Radiology. 2020 Jul 1
• 7 citations
  Central Airway Toxicity After High Dose Radiation: A Combined Analysis of Prospective Clinical Trials for Non-Small Cell Lung Cancer
  Weili Wang, Martha M. Matuszak, Chen Hu, Ke Colin Huang, Eileen Chen, Douglas A. Arenberg, Jeffrey L. Curtis, Shruti Jolly, JianYue Jin, Mitchell Machtay, Randall K. T...> ;International Journal of Radiation Oncology, Biology, Physics. 2020 Nov 1
• 5 citations
  Uptake of minimally invasive surgery and stereotactic body radiation therapy for early stage non-small cell lung cancer in the USA : An ecological study of secular tre...
  Erik F. Blom, Kevin ten Haaf, Douglas A. Arenberg, Harry J. de Koning> ;BMJ Open Respiratory Research. 2020 May 1
• 48 citations
  Disparities in Receiving Guideline-Concordant Treatment for Lung Cancer in the United States.
  Erik F. Blom, Kevin ten Haaf, Douglas A. Arenberg, Harry J. de Koning> ;Annals of the American Thoracic Society. 2020 Jan 31
• Join now to see all

Journal Articles

• Nodule Volume Measurement: pushing the Pendulum  
  Arenberg, DA, Chest, 3/1/2014
• Implementation of a Lung Cancer-Screening Program  
  Arenberg DA, Current Surgery Reports, 1/1/2013
• IASLC CT Screening Workshop 2011: Expert Pulmonary Group International Association for the Study of Lung Cancer Computed Tomography Screening Workshop 2011 report  
  Field JK , et al, J Thorac Oncol, 1/1/2012
• Changes in Global Function and Regional Ventilation and Perfusion on SPECT During the Course of Radiotherapy in Patients with Non-small Lung Cancer  
  Yuan ST, Frey KA, Gross MD, Hayman JA, Arenberg DA, Cai XW, Ramnath N, Hassan K, Moran J, Eisbruch A, Ten Haken RK, Kong FM, Int J Radiat Onco Biol Phys, 1/1/2012
• Semiquantification and Classification of Local Pulmonary Function by V/Q Single Photon Emission Computed Tomography in Patients with Non-small Cell Lung Cance: Potenti...  
  Yuan ST, Frey KA, Gross MD, Hayman JA, Arenberg DA, Curtis JL, Cai XW, Ramnath N, Kalemkerian GP, Ten Haken RK, Eisbruch A, Kong FM, J Thorac Onco, 1/1/2011
• Invited Editorial PET scans for spolitary pulmonary nodules: Costs and cost effectivelness  
  Arenberg, DA, Chest, 1/1/2010
• Time to Treatment in Patients with Stage III Non-small Cell Lung Cancer  
  Wang L, Correa CR, Hayman JA, Zhao L, Cease K, Brenner D, Arenberg D, Curtis J, Kalemkerian GP, Kong FM, Int J Radiat Oncol Biol Phys, 7/1/2009
• Expression of CD74, the Receptor for Macrophage Migration Inhibitory Factor (MIF), in Non-Small Cell Lung Cancer  
  McClelland MR, Zhao L, Carskadon SL, Arenberg DA, Am J Pathol, 1/1/2009
• Chemokines in the biology of lung cancer  
  Arenberg DA, J Thoracic Onc, 1/1/2006
• Invited Editorial In search of the Holy Grail: Lung Cancer Biomarkers  
  Arenberg, DA, Chest, 1/1/2004
• Evaluating the patient with suspected lung cancer  
  Arenberg D, J Resp Dis, 1/1/2004
• Lung cancer: selecting patients for surgery  
  Arenberg D, J Resp Dis, 1/1/2004
• Chemokines as therapeutic targets in non-small cell lung cancer  
  Arenberg D, Med Chem Rev Online, 1/1/2004
• Peroxisome proliferator activated receptor-gamma activation inhibits tumor progression in non-small cell lung cancer  
  Keshamouni VG, Reddy RC, Arenberg DA, Joel B, Thannickal VJ, Kalemkerian GP, Standiford TJ, Oncogene, 1/1/2004
•  
  White ES, Carskadon SL, Dickey EG, Livant DL, Markwart S, Arenberg DA, Am J Resp Crit Care Med, 1/1/2003
• Macrophage migration inhibitory factor (MIF) and CXC chemokine expression in human non-small cell lung cancer (NSCLC): role in angiogenesis and prognosis  
  White ES, Flaherty KR, Carskadon S, Brant A, Iannettoni MD, Yee J, Orringer MB, Arenberg, DA, Clin Can Res, 1/1/2003
• RANTES expression by lung adenocarcinoma is a predictor of survival in stage I patients  
  Moran CJ, Arenberg DA, Huang C, Giordano TJ, Thomas DG, Misek DE, Hanash S, Iannettoni MD, Orringer MB, Beer DG, Clin Can Res, 1/1/2002
• Chemokines as therapeutic targets in non-small cell lung cancer  
  White EW, Strieter RM, Arenberg DA, Curr Med Chem Anticancer Agents, 1/1/2002
• Improved survival in tumor bearing SCID mice treated with interferon-gamma-inducible protein 10 (IP-10/CXCL10)  
  Arenberg DA, White ES, Burdick MD, Strom SR, Strieter RM, Cancer Immunol Immunother, 1/1/2001
• The murine CC chemokine, 6C-kine, inhibits tumor growth and angiogenesis in a human lung cancer model  
  Arenberg DA, Zlotnick A, Strom SR, Burdick MD, Strieter RM, Cancer Immunol Immunother, 1/1/2001
• Overexpression of CXC-chemokines by an adrenocortical carcinoma: A novel clinical syndrome  
  Schteingart DE, Giordano TJ, Benitez R, Burdick M, Starkman MN, Arenberg DA, Strieter RM, J Clin Endocrinol Metab, 1/1/2001
• Monocyte-fibronectin interactions, via alpha5beta1 integrin, induce expression of CXC chemokine dependent angiogenic activity  
  White EW, Livant DL, Markwart S, Arenberg DA, J Immunol, 1/1/2001
• Non-small cell lung cancer cells induce monocytes to increase expression of angiogenic activity  
  White EW, Strom SR, Wys NB, Arenberg DA, J Immunol, 1/1/2001
• Macrophage infiltration in human non-small cell lung cancer: The role of CC chemokines  
  Arenberg DA, Keane MP, DiGiovine B, Kunkel SL, Strom SR, Burdick MD, Iannettoni MD, Strieter RM, Cancer Immunol Immunother, 1/1/2000
• The CXC chemokine, monokine induced by interferon gamma (MIG), inhibits non-small cell lung cancer (NSCLC) tumor growth and metastasis  
  Addison C, Arenberg DA, Morris SB, Xue Y, Burdick MD, Mulligan MS, Iannetoni MD, Strieter RM, Hum Gene Ther, 1/1/2000
• Join now to see all

Books/Book Chapters

• Clinical Respiratory Medicine 
  Chapter: Lung cancer Treatment, Chapter 67 
  Arenberg, DAEditors: S. Spiro, G.A. Silvestri, and A. Agusti.Edition 4th,2012
• Novel Biological Mechanisms and Impact on Clinical Practice. 
  Chapter: Angiogenic diversity and lung cancer metastasis in Lung Cancer Metastasis 
  Arenberg, DAEditors: V. Keshamouni, D. Arenberg, and G. Kalemkerian.Springer, New York, NY2009
• Lung Cancer Metastasis: Novel Biological Mechanisms and Impact on Clinical Practice. 
  Editors: V. Keshamouni, D. Arenberg, G. Kalemkerian.Springer, New York, NY2009
• The Cytokine Handbook 
  Chapter: Macrophage migration inhibitory factor (MIF). Chapter 45 
  Page 1037 - 1048Arenberg DA and Bucala REditors: A. Thomson and M. Lotze.Academic Press, London, UKEdition 4th,2003
• Inflammation: Basic Principles and Clinical Correlates. 
  Chapter: Angiogenesis. 
  Page 851 - 864Arenberg DA, Strieter RMEditors: J. Gallin and R. Snyderman.Lippincott Williams & Wilkins, Philadelphia, PAEdition 3rd,1999
• Chemokines and Cancer 
  Chapter: CXC chemokines and lung cancer angiogenesis. 
  Page 3 - 19Strieter RM, DiGiovine B, Polverini PJ, Kunkel SL, Shanafelt A, Hesselgesser J, Horuk R, Arenberg DAEditors: Barrett J. Rollins.Humana Press, Totowa, NJ1999
• Chemokines in Disease: Biology and Clinical Research. 
  Chapter: The role of CXC chemokines in the regulation of angiogenesis in non-small cell lung cancer. 
  Page 171 - 182Strieter RM, Addison CA, Moore BB, Arenberg DAEditors: C. Hebert.Humana Press, Totowa, NJ1999
• Molecular and Cellular Basis of Inflammation. 
  Chapter: Angiogenesis. 
  Page 29 - 49Arenberg DA, Strieter RMEditors: C. Serhan and P. Ward.Humana Press, Totowa, NJ1999
• The Role of Chemokines in Disease. 
  Chapter: The role of CXC chemokines in regulation of angiogenesis. 
  Page 195 - 210Strieter RM, Kunkel SL, Shanafelt AB, Arenberg DA, Koch AE, Polverini PJEditors: A. Koch and R. Strieter.Landes Co. Publishers, Austin, TX1996
• Murray & Nadel’s Textbook of Respiratory Medicine 
  Chapter: Metastatic Lung Tumors. Chapter 49 
  Arenberg, DA, Pickens, AEditors: Mason, R., Broaddus, V.C., King, T., Schraufnagel, D., Martin, T.R., Murray, J.F., Nadel, J..Edition 5th,
• Join now to see all

Abstracts/Posters

• Lung injury accelerates growth of lung cancer cells in an orthotopic model of lung cancer.
  Arenberg DA, Carskadon SL, Zhao L, American Thoracic Society, Toronto, Ontario, Canada, 5/1/2008
• The tumor microenvironment modulates the angiogenic phenotype in lung cancer. Diversity and plasticity of the angiogenic switch in lung cancer.
  Arenberg DA, Carskadon SL, Zhao L, White ES McClelland MR, American Thoracic Society, San Diego, CA, 5/1/2007
• Diversity and plasticity of the angiogenic switch in lung cancer.
  McClelland MR, Carskadon SL, Zhao L, White ES, Arenberg DA, American Thoracic Society, San Diego, CA, 5/1/2006
• Tumor derived fibroblasts are pro-angiogenic.
  McClelland M, Gray A, Carskadon S, Zhao L, and Arenberg DA, American Thoracic Society, San Diego, CA, 5/1/2005
• Oxidase-Dependent Expression of Angiogenic Activity by Non-small Cell Lung Cancer Cells
  Arenberg DA, Carskadon SL, Thannickal VJ and Keshamouni, V, American Thoracic Society, Orlando, FL, 5/1/2004
• Tumor Derived Fibroblasts in Lung Cancer; A Distinct Sub-population of Lung Fibroblasts.
  Arenberg DA, Gray A, Carskadon SL, White ES, AACR, Orlando, FL, 3/1/2004
• GP91phox-dependent Expression of Angiogenic CXC Chemokines in Human Non-Small Cell Lung Cancer.
  Arenberg DA, Carskadon SL, Thannickal VJ, The Thomas Petty Aspen Lung Conference, 6/1/2003
• H2O2-dependent Expression of Angiogenic CXC Chemokines by Human Non-Small Cell Lung Cancer Cells.
  Arenberg DA, Carskadon SL, Thannickal VJ, AACR, Toronto, Ontario, Canada, 4/1/2003
• Evidence for Selective PPAR Modulation in Lung Cancer.
  Keshamouni V, Joel B, Reddy R, Arenberg DA, Standiford T, Keystone Symposia on PPAR, 2/1/2003
• Macrophage Migration Inhibitory Factor (MIF) Promotes Chemokine Mediated Angiogenesis In Lung Cancer.
  Arenberg DA, White ES, Carskaddon S, ATS, Seattle, WA, 1/1/2003
• Redox regulation of apoptotic resistance in lung cancer cells.
  Keshamouni V, Arenberg DA, Joel B, Reddy R, Standiford T, Thannickal VJ, ATS, Seattle, WA, 1/1/2003
• Peroxisome Proliferator-Activated Receptor (PPAR) Agonists Impede Growth in Non-Small Cell Lung Cancer By Inhibiting Cell Proliferation and Angiogenesis.
  Keshamouni V, Reddy R, Joel B, Arenberg DA, Newstead M, Standiford T, ATS, Seattle, WA, 1/1/2003
• Basement Membrane Invasion by Lung Fibroblasts from IPF: Role of paxillin and pp125FAK.
  White ES, Carskadon SL, Dickey EG, Arenberg DA, ATS, Seattle, WA, 1/1/2003
• Invasive Behavior of Lung Fibroblasts from Fibrotic Diseases: Role of the alpha4beta1 and alpha5beta1 Integrins.
  White ES, Carskadon SL, Dickey EG, Arenberg DA, ATS, Seattle, WA, 1/1/2003
• Expression of macrophage migration inhibitory factor (MIF) in human non-small cell lung cancer (NSCLC).
  Arenberg DA, Carskaddon S, White ES, Midwest Section-AFMR, Chicago, IL, 9/1/2002
• Macrophage infiltration of murine lung cancer tumors: role in angiogenesis.
  Arenberg DA, White E and Carskaddon S, Am J Respir Crit Care Med, 1/1/2002
• Macrophage migration inhibitory factor (MIF) in pulmonary fibrosis.
  Lama VN, Arenberg D, Flaherty K, Moore B, Kazerooni E, Standiford T, Toews G, Martinez FJ, Am J Respir Crit Care Med, 1/1/2002
• Fibrotic-lung fibroblast invasion of basement membranes is modulated by PTEN.
  White ES, Carskadon SL, Livant DL, Markwart S, Toews GB, Arenberg DA, Am J Respir Crit Care Med, 1/1/2002
• Induction of chemokine dependent angiogenic activity by macrophage migration inhibitory factor (MIF).
  Arenberg DA, Wys NL, and White E, Keystone Symposium on Chemokines and Chemokine Receptors, Taos, NM, 2/1/2001
• Migration inhibitory factor (MIF) expression in lung cancer promotes angiogenesis.
  Arenberg DA, Wys N, White ES, Am J Respir Crit Care Med, 1/1/2001
• White ES, Wys NL, and Arenberg DA, Am J Respir Crit Care Med, 1/1/2001
• Inhibition of lung cancer derived chemokine expression by atorvastatin.
  Arenberg DA and Wys N, FASEB J, 1/1/2001
• Fibronectin is a Key Mediator of Macrophage-Derived Angiogenic Activity.
  White ES, Wys N, Strom SR, Arenberg D, Cytokines and Cancer: Regulation, Angiogenesis, and Clinical Applications. American Association for Cancer Research, 9/20/2000
• Angiostatic and anti-tumor activity of interferon-gamma (IFNgamma) in SCID mice.
  Arenberg DA, Strom S, Keane M, Kunkel S, Burdick M, Strieter R, Am J Respir Crit Care Med, 1/1/2000
• IL-12 attenuates bleomycin-induced pulmonary fibrosis by inducing expression of IFN-gamma.
  Keane MP, Belperio JA, Arenberg DA, Burdick MD, Strieter RM, Am J Respir Crit Care Med, 1/1/2000
• Join now to see all

Lectures

• Cellvizio Pulmonary Roundtable Discussion. Invited Speaker 
  12/1/2014
• Key Components of a Lung Cancer Screening Program. Invited Speaker 
  Gratiot Hospital, Midland, MI - 11/1/2014
• Emerging Science and Therapies in Lung Cancers 
  New York, NY - 11/1/2014
• Lung Cancer Evaluation and Treatment: an Evolving Paradigm. Chair, Invited Speaker 
  Austin, TX - 10/1/2014
• PET Scans: The Swiss Army Knife of Thoracic Oncology. Chair and Invited Speaker 
  Austin, TX - 10/1/2014
• What is Multifocal Lung Cancer, and How Do We Manage IT? Panel Discussion 
  Austin, TX - 10/1/2014
• Bais, Bonsuses and Benfits: Understanding of Data from Lung Cancer Screening Trails. Invited Speaker 
  Troy, MI - 10/1/2014
• Pulmonary Nodule Workup 
  University of Michigan , Ann Arbor, MI - 9/10/2014
• Technical and Practical Aspects fo Bronchscopy 
  University of Michigan , Ann Arbor, MI - 9/6/2014
• Lung Cancer Screening 
  University of Michigan , Ann Arbor, MI - 8/8/2014
• Cell and Molecular Biology Lecture 
  Chicago, IL - 8/1/2014
• Neoplasms Lecture 
  Chicago, IL - 8/1/2014
• Implementation of Lung Cancer Screening. Invited Speaker and Participant 
  San Deigo, CA - 5/1/2014
• Diagnosis and Management of Lung Cancer. Chair and Speaker 
  San Antonio, TX - 3/1/2014
• ACCP Lung Cancer III Guidelines: Treatment of Early Lung Cancer (NSCLC). Speaker 
  Chicago, IL - 10/1/2013
• Diagnostic Approach to the Patient With Suspected Lung Cancer. Invited Speaker 
  Chicago, IL - 10/1/2013
• Lung Cancer Screening: Practical Lessons From Early Experiences. Invited Speaker 
  Chicago, IL - 10/1/2013
• Present and Future Targeted Lung Cancer Therapy: Beginning the End of Nihilism. Chair and Invited Speaker 
  Chicago, IL - 10/1/2013
• Synergistic Perspectives in NSCLC Management. Invited Speaker 
  Chicago, IL - 9/1/2013
• Pulmonary Board Review. Invited Speaker 
  Chicago, IL - 8/1/2013
• Lung Cancer 
  University of Michigan , Ann Arbor, MI - 7/19/2013
• Diagnosis and Staging of Lung Cancer 
  University of Michigan , Ann Arbor, MI - 7/9/2013
• Internal Medicine Update, Speaker 
  Mackinac Island, MI - 7/1/2013
• Clinical Challenges, Practicing in the Absence of Data: Stage III lung cancer; Who gets surgery? 
  5/1/2013
• Lung cancer Screening: Moving Forward. Symposium Chair and Speaker 
  5/1/2013
• Join now to see all